Long-term efficacy and pharmacodynamic parameter analysis in pretreated KRAS-mutant metastatic colorectal carcinoma (mCRC) patients treated with RG7160 (GA201), an antibody-dependent cellular cytotoxicity (ADCC)-enhanced monoclonal anti-EGFR antibody (2013)
Attributed to:
BRIC: Packaging cell lines for inherently manufacturable viral vectors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 31
Parent Publication: JOURNAL OF CLINICAL ONCOLOGY
Issue: 4
ISSN: 0732-183X